KeyBank National Association’s Acceleron Pharma XLRN Stock Holding History

KeyBank National Association’s Portfolio XLRN Stock Details XLRN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,163	Closed	-$200K	–	1116
2021 Q3	$200K	Buy	+1,163	New	+$152K	﹤0.01%	1030

KeyBank National Association's XLRN Position: Q4 2021 in Review

KeyBank National Association sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 1,163 shares — an estimated $200K sold.

KeyBank National Association first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $200K in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

KeyBank National Association reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
KeyBank National Association sold 1,163 Acceleron Pharma shares in Q4 2021, an estimated $200K.
KeyBank National Association first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
KeyBank National Association's Acceleron Pharma position peaked at $200K in Q3 2021.
1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on KeyBank National Association's 13F filing for Q4 2021, filed 7 Feb 2022.